TGF-β has been identified as a key regulator of EMT in cancer, by the polarization of TAMs and activation of CAFs to induce the NFκ-B pathway and produce hypoxia-inducible factor (HIF-1) to drive expression of EMT proteins [96]. This evidence concerns the gene TGFB1 and cancer.